Conclusion
Our data suggests that low FT3 levels at admission are independently
associated with poor outcome in acute ischemic stroke after 3 months.
Further investigations are needed to explore the mechanisms underlying
the association and their potential exploitation in terms of therapeutic
strategies to reduce disability after acute ischemic stroke.